Short Interest in Talphera, Inc. (NASDAQ:TLPH) Expands By 42.4%

Talphera, Inc. (NASDAQ:TLPH) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 104,100 shares, a growth of 42.4% from the February 28th total of 73,100 shares. Currently, 0.6% of the company’s stock are short sold. Based on an average daily volume of 75,500 shares, the days-to-cover ratio is currently 1.4 days.

Talphera Trading Down 14.2 %

Shares of NASDAQ:TLPH traded down $0.08 on Monday, reaching $0.50. 382,156 shares of the company’s stock were exchanged, compared to its average volume of 77,435. Talphera has a twelve month low of $0.44 and a twelve month high of $1.27. The company has a fifty day moving average of $0.61 and a 200-day moving average of $0.71. The company has a market capitalization of $8.57 million, a price-to-earnings ratio of -0.73 and a beta of 0.20.

Wall Street Analyst Weigh In

Several research firms recently weighed in on TLPH. HC Wainwright reissued a “buy” rating and issued a $6.00 target price on shares of Talphera in a research note on Tuesday, January 21st. RODMAN&RENSHAW upgraded shares of Talphera to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Rodman & Renshaw began coverage on shares of Talphera in a research note on Tuesday, January 28th. They issued a “buy” rating and a $4.00 price target on the stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.